GenomOncology and Congenica Announce Collaborative Development of Novel Precision Oncology Solution – QNT Press Release


Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for the development of a novel ground-breaking CE-IVD Precision Oncology Solution.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220803005517/en/

Alistair Johnson is Chief Professional Services Officer at Congenica (Photo: Business Wire)

Driven by the increasing adoption of cancer genomics and the growing need to individualize therapeutic recommendations, Congenica is developing a fully automated data analysis application, aimed at transforming the usability and scalability of genomic data for routine oncology clinical practice.

To further enrich decision support capabilities for this novel precision oncology solution, Congenica is collaborating with GenomOncology to provide regional therapy recommendations.

GenomOncology’s Precision Oncology Platform is designed to harmonize the latest precision oncology information, which includes an …

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center